Prolonged paralysis related to mivacurium: a case study.
Pseudocholinesterase deficiency is usually identified when an anesthetized patient has prolonged paralysis after receiving neuromuscular blocking agents dependent on pseudocholinesterase enzymes for hydrolysis. This rare complication, most frequently associated with succinylcholine, can occur with the use of mivacurium, one of the newer nondepolarizing muscle relaxants also hydrolyzed by pseudocholinesterase. Prolonged paralysis has occurred 3 times in the past 2 years at this pediatric hospital after administration of mivacurium. The following case study describes causality and interventions for a patient with prolonged paralysis after receiving mivacurium.
Kendrick
Kathy
K
PACU and Day Surgery, Children's Healthcare of Atlanta at Egleston, 1405 Clifton Road NE, Atlanta, GA 30322, USA. kathy.kendrick@choa.org
D000293:Adolescent; D002091:Butyrylcholinesterase / Q000172:deficiency*; D002547:Cerebral Palsy / Q000150:complications; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000009:adverse effects*; D000077590:Mivacurium; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D010243:Paralysis / Q000139:chemically induced* / Q000451:nursing; D016528:Postanesthesia Nursing; D011183:Postoperative Complications / Q000139:chemically induced* / Q000451:nursing
D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D000077590:Mivacurium; D002091:Butyrylcholinesterase